<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">38808198</PMID><DateRevised><Year>2024</Year><Month>05</Month><Day>30</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2050-0904</ISSN><JournalIssue CitedMedium="Print"><Volume>12</Volume><Issue>6</Issue><PubDate><Year>2024</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Clinical case reports</Title><ISOAbbreviation>Clin Case Rep</ISOAbbreviation></Journal><ArticleTitle>Long COVID-19 leading to Good's syndrome diagnosis: A clinical case-report and literature review.</ArticleTitle><Pagination><StartPage>e8962</StartPage><MedlinePgn>e8962</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e8962</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1002/ccr3.8962</ELocationID><Abstract><AbstractText Label="KEY CLINICAL MESSAGE" NlmCategory="UNASSIGNED">Good's syndrome (GS) in conjunction with a severe COVID-19 infection, shedding light on the complexities of managing this rare condition that combines thymoma and immunodeficiency.</AbstractText><AbstractText Label="ABSTRACT" NlmCategory="UNASSIGNED">This study delves into the clinical presentation and management of a 63-year-old male diagnosed with Good's syndrome (GS) amid a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. GS, an uncommon association between thymoma and immunodeficiency, remains a clinical mystery, necessitating increased awareness and understanding. Our patient's intricate clinical course, marked by recurrent COVID-19 symptoms and multiple hospitalizations, exemplifies the challenges posed by GS. Through a systematic review of GS cases globally, we highlight its worldwide distribution, with a substantial proportion reported in Europe. Notably, the diagnosis of thymoma often precedes immunodeficiency, emphasizing the importance of vigilance in clinical assessments.</AbstractText><CopyrightInformation>&#xa9; 2024 The Author(s). Clinical Case Reports published by John Wiley &amp; Sons Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tabarsi</LastName><ForeName>Payam</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0001-6786-1524</Identifier><AffiliationInfo><Affiliation>Clinical Tuberculosis and Epidemiology Research Center, National Research Institute for Tuberculosis and Lung Disease (NRITLD) Shahid Beheshti University of Medical Sciences Tehran Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hemmatian</LastName><ForeName>Marjan</ForeName><Initials>M</Initials><Identifier Source="ORCID">0009-0006-2236-2303</Identifier><AffiliationInfo><Affiliation>Infectious Diseases and Tropical Medicine, Loghman Hospital, School of Medicine Shahid Beheshti University of Medical Sciences Tehran Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moradi</LastName><ForeName>Maryam</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-3675-0500</Identifier><AffiliationInfo><Affiliation>Eye Research Center, The Five Senses Health Institute, Rassoul Akram Hospital Iran University of Medical Sciences Tehran Iran.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>05</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Clin Case Rep</MedlineTA><NlmUniqueID>101620385</NlmUniqueID><ISSNLinking>2050-0904</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID&#x2010;19</Keyword><Keyword MajorTopicYN="N">Good's syndrome</Keyword><Keyword MajorTopicYN="N">SARS&#x2010;CoV&#x2010;2</Keyword><Keyword MajorTopicYN="N">long COVID&#x2010;19</Keyword></KeywordList><CoiStatement>None.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>2</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>3</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>4</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>5</Month><Day>29</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>5</Month><Day>29</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>5</Month><Day>29</Day><Hour>3</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>5</Month><Day>27</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38808198</ArticleId><ArticleId IdType="pmc">PMC11130229</ArticleId><ArticleId IdType="doi">10.1002/ccr3.8962</ArticleId><ArticleId IdType="pii">CCR38962</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Daniel SJ. Education and the COVID&#x2010;19 pandemic. Prospects. 2020;49(1):91&#x2010;96.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7167396</ArticleId><ArticleId IdType="pubmed">32313309</ArticleId></ArticleIdList></Reference><Reference><Citation>Sachs JD, Karim SSA, Aknin L, et&#xa0;al. The lancet commission on lessons for the future from the COVID&#x2010;19 pandemic. Lancet. 2022;400(10359):1224&#x2010;1280.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9539542</ArticleId><ArticleId IdType="pubmed">36115368</ArticleId></ArticleIdList></Reference><Reference><Citation>Msemburi W, Karlinsky A, Knutson V, Aleshin&#x2010;Guendel S, Chatterji S, Wakefield J. The WHO estimates of excess mortality associated with the COVID&#x2010;19 pandemic. Nature. 2023;613(7942):130&#x2010;137.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9812776</ArticleId><ArticleId IdType="pubmed">36517599</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh J, Kumar N, Dinkar A. Demographic, clinical, and investigational characteristics of COVID&#x2010;19&#x2010;related Guillain&#x2010;Barr&#xe9; syndrome with differences from typical and another virus&#x2010;related Guillain&#x2010;Barr&#xe9; syndrome. Infect Disord Drug Targets. 2022;22(7):27&#x2010;38.</Citation><ArticleIdList><ArticleId IdType="pubmed">35507796</ArticleId></ArticleIdList></Reference><Reference><Citation>Desai AD, Lavelle M, Boursiquot BC, Wan EY. Long&#x2010;term complications of COVID&#x2010;19. Am J Physiol Cell Physiol. 2022;322(1):C1&#x2010;C11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8721906</ArticleId><ArticleId IdType="pubmed">34817268</ArticleId></ArticleIdList></Reference><Reference><Citation>Sipos F, M&#x171;zes G. Good's syndrome: brief overview of an enigmatic immune deficiency. APMIS. 2023;131(12):698&#x2010;704.</Citation><ArticleIdList><ArticleId IdType="pubmed">37729389</ArticleId></ArticleIdList></Reference><Reference><Citation>Le Gatt P, Nguyen AT, Baaroun V, Rochefort J. Oral lichen planus in patients with Good's syndrome: a literature review. Cureus. 2023;15(2):e35177.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10029699</ArticleId><ArticleId IdType="pubmed">36960269</ArticleId></ArticleIdList></Reference><Reference><Citation>Kelesidis T, Yang O. Good's syndrome remains a mystery after 55&#x2009;years: a systematic review of the scientific evidence. Clin Immunol. 2010;135(3):347&#x2010;363.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8071094</ArticleId><ArticleId IdType="pubmed">20149753</ArticleId></ArticleIdList></Reference><Reference><Citation>Kelleher P, Misbah S. What is Good's syndrome? Immunological abnormalities in patients with thymoma. J Clin Pathol. 2003;56(1):12&#x2010;16.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1769851</ArticleId><ArticleId IdType="pubmed">12499426</ArticleId></ArticleIdList></Reference><Reference><Citation>Cos Esquius ML, L&#xf3;pez Montesinos I, Gimeno Martinez R, et&#xa0;al. Severe COVID&#x2010;19 pneumonia in good syndrome with a favorable outcome. Clin Immunol. 2022;235:108789.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8239200</ArticleId><ArticleId IdType="pubmed">34197951</ArticleId></ArticleIdList></Reference><Reference><Citation>Pozzi MR, Baronio M, Janetti MB, et&#xa0;al. Fatal SARS&#x2010;CoV&#x2010;2 infection in a male patient with Good's syndrome. Clin Immunol. 2021;223:108644.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7722520</ArticleId><ArticleId IdType="pubmed">33301884</ArticleId></ArticleIdList></Reference><Reference><Citation>Berzenji L, Yogeswaran SK, Snoeckx A, Van Schil PE, Wener R, Hendriks JMH. Good's syndrome and COVID&#x2010;19: case report and literature review. Mediastinum. 2023;7:5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10011861</ArticleId><ArticleId IdType="pubmed">36926289</ArticleId></ArticleIdList></Reference><Reference><Citation>Maldonado&#x2010;Dom&#xed;nguez ED, Farrill&#x2010;Romanillos PMO . Patient with Good's syndrome and COVID&#x2010;19. Report of a clinical case. Rev Med Inst Mex Seguro Soc. 2022;60(4):474&#x2010;479.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10395876</ArticleId><ArticleId IdType="pubmed">35819306</ArticleId></ArticleIdList></Reference><Reference><Citation>Duarte M, Faria L, Patronillo C, da Costa FS, Seara V. A case of severe COVID&#x2010;19 in a patient with Good's syndrome. Eur J Case Rep Intern Med. 2021;8(10):002976.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8592660</ArticleId><ArticleId IdType="pubmed">34790632</ArticleId></ArticleIdList></Reference><Reference><Citation>Agarwal S, Cunningham&#x2010;Rundles C. Thymoma and immunodeficiency (Good syndrome): a report of 2 unusual cases and review of the literature. Ann Allergy Asthma Immunol. 2007;98(2):185&#x2010;190.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3102047</ArticleId><ArticleId IdType="pubmed">17304889</ArticleId></ArticleIdList></Reference><Reference><Citation>Malphettes M, G&#xe9;rard L, Galicier L, et&#xa0;al. Good syndrome: an adult&#x2010;onset immunodeficiency remarkable for its high incidence of invasive infections and autoimmune complications. Clin Infect Dis. 2015;61(2):e13&#x2010;e19.</Citation><ArticleIdList><ArticleId IdType="pubmed">25828999</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh J, Dinkar A, Kumar N, Kumar K. COVID&#x2010;19 associated pancytopenia (CAP): a clinical impact. Recent Adv Inflamm Allergy Drug Discov. 2023;17(1):71&#x2010;78.</Citation><ArticleIdList><ArticleId IdType="pubmed">36475340</ArticleId></ArticleIdList></Reference><Reference><Citation>Multani A, Gomez CA, Montoya JG. Prevention of infectious diseases in patients with Good syndrome. Curr Opin Infect Dis. 2018;31(4):267&#x2010;277.</Citation><ArticleIdList><ArticleId IdType="pubmed">29878906</ArticleId></ArticleIdList></Reference><Reference><Citation>Miyakis S, Pefanis A, Passam FH, Christodulakis GR, Roussou PA, Mountokalakis TD. Thymoma with immunodeficiency (Good's syndrome): review of the literature apropos three cases. Scand J Infect Dis. 2006;38(4):314&#x2010;320.</Citation><ArticleIdList><ArticleId IdType="pubmed">16718939</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>